About biote Corp.
https://biote.combiote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements.
CEO
Bret Christensen
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 45
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
325 CAPITAL LLC
Shares:4.55M
Value:$10.82M
BANDERA PARTNERS LLC
Shares:2.28M
Value:$5.44M
BLACKROCK, INC.
Shares:1.74M
Value:$4.15M
Summary
Showing Top 3 of 93
About biote Corp.
https://biote.combiote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $47.96M ▼ | $26.15M ▲ | $8.19M ▲ | 17.07% ▲ | $0.26 ▲ | $12.14M ▲ |
| Q2-2025 | $48.86M ▼ | $24.22M ▼ | $3.19M ▼ | 6.52% ▼ | $0.1 ▼ | $9.84M ▼ |
| Q1-2025 | $48.99M ▼ | $26.69M ▼ | $13.72M ▲ | 28% ▲ | $0.44 ▲ | $21.22M ▲ |
| Q4-2024 | $49.83M ▼ | $32.76M ▲ | $3.7M ▼ | 7.43% ▼ | $0.12 ▼ | $3.14M ▼ |
| Q3-2024 | $51.38M | $24.03M | $10.7M | 20.83% | $0.34 | $20.21M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $28.05M ▲ | $111.32M ▲ | $176.79M ▼ | $-72.75M ▲ |
| Q2-2025 | $19.6M ▼ | $104.8M ▼ | $183.64M ▼ | $-85.1M ▲ |
| Q1-2025 | $41.7M ▲ | $123.38M ▲ | $208.21M ▼ | $-89.98M ▲ |
| Q4-2024 | $39.34M ▲ | $122.37M ▲ | $224.57M ▼ | $-105.93M ▲ |
| Q3-2024 | $38.23M | $101.25M | $228.08M | $-130.34M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $9.22M ▲ | $14.07M ▲ | $-690K ▲ | $-4.93M ▲ | $8.45M ▲ | $13.38M ▲ |
| Q2-2025 | $3.92M ▼ | $7.09M ▲ | $-1.96M ▼ | $-27.23M ▼ | $-22.1M ▼ | $5.28M ▲ |
| Q1-2025 | $15.84M ▲ | $6.47M ▼ | $-1.85M ▼ | $-2.26M ▲ | $2.36M ▲ | $4.84M ▼ |
| Q4-2024 | $3.48M ▼ | $12.37M ▼ | $-1.31M ▲ | $-9.93M ▼ | $1.12M ▼ | $11.29M ▼ |
| Q3-2024 | $4.96M | $15.56M | $-1.97M | $-1.77M | $11.81M | $13.58M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Dietary Supplements | $20.00M ▲ | $10.00M ▼ | $10.00M ▲ | $10.00M ▲ |
 Other Service Revenue | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Product Revenue | $100.00M ▲ | $50.00M ▼ | $50.00M ▲ | $50.00M ▲ |
 Service Revenue | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Training Service Revenue | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 All Other Country | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 UNITED STATES | $100.00M ▲ | $50.00M ▼ | $50.00M ▲ | $50.00M ▲ |
CEO
Bret Christensen
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 45
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
325 CAPITAL LLC
Shares:4.55M
Value:$10.82M
BANDERA PARTNERS LLC
Shares:2.28M
Value:$5.44M
BLACKROCK, INC.
Shares:1.74M
Value:$4.15M
Summary
Showing Top 3 of 93